Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Fibrocell Science (FCSC)

0.7042 -0.056 (-7.34%)

05-22 16:00

Open:

0.75

Pre. Close:

0.76

High:

0.7545

Low:

0.6512

Volume:

1,489,745

Market Cap:

20M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.751 - 0.757

0.757 - 0.761

Low:

0.639 - 0.645

0.645 - 0.649

Close:

0.692 - 0.702

0.702 - 0.708

Technical analysis  (as of: 2018-05-22 4:38:52 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 0.95     One year: 1.13

Support:

Support1: 0.55    Support2: 0.46

Resistance:

Resistance1: 0.81    Resistance2: 0.97

Pivot:

0.65

Moving Averages:

MA(5): 0.76     MA(20): 0.63

MA(100): 0.64     MA(250): 1.81

MACD:

MACD(12,26): 0.04     Signal(12,26,9): 0.02

%K %D:

%K(14,3): 48.75     %D(3): 62.28

RSI:

RSI(14): 54.52

52-Week:

High: 4.64  Low: 0.51  Change(%): -72.6

Average Vol(K):

3-Month: 58476  10-Days 205588

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
FCSC has closed below upper band by 37.4%. Bollinger Bands are 209.6% wider than normal. The large width of the bands suggest high volatility as compared to FCSC's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.

Headline News

2018-05-22T18:00:00-04:00
Your Daily Pharma Scoop: Sesen Bio Presents Vicinium Data, UroGen's Mitogel Data, FibroGen In IPF

2018-05-22T14:19:03-04:00
Fibrocell Science (FCSC) Updates On FCX-007 Interim Data - Slideshow

2018-05-22T12:03:38-04:00
Core Biotech Buys #16: Taking Advantage Of Weakness To Add To Conviction Ideas

2018-05-21T12:15:23-04:00
Fibrocell's gene therapy FCX-007 shows positive effect in RDEB study; shares up 4%

2018-05-10T11:24:08-04:00
Fibrocell Science's (FCSC) CEO John Maslowski on Q1 2018 Results - Earnings Call Transcript

2018-04-18T08:24:40-04:00
Fibrocell Science to explore strategic alternatives

2018-04-09T07:19:12-04:00
Novartis takeout of AveXis stokes buying in gene therapy players

2018-03-19T13:40:05-04:00
Fibrocell Science's (FCSC) CEO John Maslowski on Q4 2017 Results - Earnings Call Transcript

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

28.36

Shares Float (M)

24.70

% Held by Insiders

14.10

% Held by Institutions

36.20

Shares Short (K)

706

Shares Short Prior Month (K)

756

Stock Financials

EPS

-1.410

EPS Est. Current Year

-2.170

EPS Est. Next Year

-1.060

EPS Est. Next Quarter

-0.350

Forward EPS

-0.629

Book Value (p.s.)

2.010

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-105.7

Return on Equity (ttm)

-244.3

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.476

Qtrly Earnings Growth

Operating Cash Flow (M)

-17.04

Levered Free Cash Flow (M)

-10.56

atoplab.com

Valuation

P/E

-0.50

P/E Growth Ratio

-0.07

P/BV

0.35

P/S

P/CF

-1.17

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2017-03-13

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.